Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors.

Weidenbacher PA, Waltari E, de Los Rios Kobara I, Bell BN, Morris MK, Cheng YC, Hanson C, Pak JE, Kim PS
Nat Chem Biol. 2022 Nov;18(11):1270-1276. doi: 10.1038/s41589-022-01140-1. Epub 2022 Sep 8. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.